ONTOLOGY REPORT - ANNOTATIONS
| Term: | cadmium dichloride |
|
| Accession: | CHEBI:35456
|
browse the term
|
| Definition: | A cadmium coordination entity that has formula CdCl2. |
| Synonyms: | exact_synonym: | cadmium(2+) chloride; cadmium(II) chloride |
| | related_synonym: | Caddy; CdCl2; Cl[Cd]Cl; Dichlorocadmium; InChI=1S/Cd.2ClH/h;2*1H/q+2;;/p-2; InChIKey=YKYOUMDCQGMQQO-UHFFFAOYSA-L; Kadmiumchlorid; cadmium chloride |
| | xref_casrn: | 10108-64-2 |
| | xref: | ChEMBL:982764 "ChEMBL COMPOUND"; ChemIDplus:10108-64-2 "CAS Registry Number"; Gmelin:912918 "Gmelin Registry Number"; KEGG COMPOUND:C15233 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D019256 |
| | xref: | MolBase:1667 "MolBase"; NIST Chemistry WebBook:10108-64-2 "CAS Registry Number" |
|
|
cadmium dichloride
|
| G |
0610031J06Rik |
RIKEN cDNA 0610031J06 gene |
|
decreases expression |
ISO |
3 |
88,128,945 |
88,132,553 |
RGD:6480464 |
CTD |
| G |
1700007K13Rik |
RIKEN cDNA 1700007K13 gene |
|
increases expression |
ISO |
2 |
28,317,521 |
28,321,844 |
RGD:6480464 |
CTD |
| G |
2310061I04Rik |
RIKEN cDNA 2310061I04 gene |
|
decreases methylation |
ISO |
17 |
36,029,622 |
36,034,323 |
RGD:6480464 |
CTD |
| G |
3230401D17Rik |
RIKEN cDNA 3230401D17 gene |
|
increases expression |
ISO |
2 |
163,231,558 |
163,245,206 |
RGD:6480464 |
CTD |
| G |
6430573F11Rik |
RIKEN cDNA 6430573F11 gene |
|
decreases methylation |
ISO |
8 |
37,552,245 |
37,576,067 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, sub-family G (WHITE), member 2 |
|
increases expression |
ISO |
6 |
58,546,666 |
58,642,445 |
RGD:6480464 |
CTD |
| G |
Abhd4 |
abhydrolase domain containing 4 |
|
increases expression |
EXP |
14 |
54,878,972 |
54,888,840 |
RGD:6480464 |
CTD |
| G |
Acaa1a |
acetyl-Coenzyme A acyltransferase 1A |
|
increases expression |
ISO |
9 |
119,250,412 |
119,259,413 |
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
decreases activity |
ISO |
5 |
137,729,505 |
137,735,691 |
RGD:6480464 |
CTD |
| G |
Acot8 |
acyl-CoA thioesterase 8 |
|
decreases expression |
ISO |
2 |
164,618,268 |
164,630,381 |
RGD:6480464 |
CTD |
| G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
|
decreases expression |
ISO |
11 |
116,033,202 |
116,060,359 |
RGD:6480464 |
CTD |
| G |
Acp1 |
acid phosphatase 1, soluble |
|
increases expression |
ISO |
12 |
31,578,191 |
31,596,477 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
decreases expression |
ISO |
8 |
126,415,667 |
126,418,636 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
increases expression |
ISO |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
5 |
143,664,795 |
143,668,403 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
decreases expression |
ISO |
16 |
35,155,722 |
35,304,635 |
RGD:6480464 |
CTD |
| G |
Adh6a |
alcohol dehydrogenase 6A (class V) |
|
decreases expression |
ISO |
3 |
137,976,250 |
137,994,098 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
multiple interactions |
ISO |
1 |
136,095,799 |
136,132,008 |
RGD:6480464 |
CTD |
| G |
Afap1l2 |
actin filament associated protein 1-like 2 |
|
decreases expression |
ISO |
19 |
56,986,844 |
57,083,065 |
RGD:6480464 |
CTD |
| G |
Agpat5 |
1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon) |
|
increases expression |
EXP |
8 |
18,846,279 |
18,884,413 |
RGD:6480464 |
CTD |
| G |
Agxt2 |
alanine-glyoxylate aminotransferase 2 |
|
increases expression |
ISO |
15 |
10,288,334 |
10,339,493 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
increases secretion |
ISO |
X |
45,828,121 |
45,866,603 |
RGD:6480464 |
CTD |
| G |
Akr1b3 |
aldo-keto reductase family 1, member B3 (aldose reductase) |
|
decreases expression |
ISO |
6 |
34,253,930 |
34,267,489 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase family 6, subfamily A1 |
|
decreases expression |
ISO |
12 |
85,771,667 |
85,791,900 |
RGD:6480464 |
CTD |
| G |
Aloxe3 |
arachidonate lipoxygenase 3 |
|
increases expression |
ISO |
11 |
68,939,879 |
68,962,617 |
RGD:6480464 |
CTD |
| G |
Ankrd60 |
ankyrin repeat domain 60 |
|
increases expression |
ISO |
2 |
173,394,165 |
173,403,842 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Apba1 |
amyloid beta (A4) precursor protein binding, family A, member 1 |
|
multiple interactions |
ISO |
19 |
23,833,366 |
24,024,087 |
RGD:6480464 |
CTD |
| G |
Aph1b |
anterior pharynx defective 1b homolog (C. elegans) |
|
increases expression |
ISO |
9 |
66,623,294 |
66,643,230 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases activity |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
increases activity |
EXP |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
EXP |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Arhgap5 |
Rho GTPase activating protein 5 |
|
decreases expression |
ISO |
12 |
53,617,064 |
53,668,839 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
increases expression |
ISO |
11 |
120,438,549 |
120,442,934 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
decreases expression |
ISO |
11 |
120,438,549 |
120,442,934 |
RGD:6480464 |
CTD |
| G |
Arih2 |
ariadne homolog 2 (Drosophila) |
|
increases expression |
EXP |
9 |
108,505,273 |
108,551,711 |
RGD:6480464 |
CTD |
| G |
Astn2 |
astrotactin 2 |
|
increases expression |
ISO |
4 |
65,041,837 |
66,065,517 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
increases expression |
EXP |
15 |
100,058,290 |
100,091,679 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases expression |
EXP |
2 |
73,654,578 |
73,730,685 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
1 |
192,994,175 |
193,007,212 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
ISO |
3 |
101,380,146 |
101,408,580 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
increases expression |
ISO |
7 |
133,589,374 |
133,606,587 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
ISO |
10 |
98,377,786 |
98,488,777 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
ISO |
2 |
121,973,423 |
121,978,818 |
RGD:6480464 |
CTD |
| G |
Bach1 |
BTB and CNC homology 1 |
|
multiple interactions |
EXP |
16 |
87,699,199 |
87,733,591 |
RGD:6480464 |
CTD |
| G |
Bach2 |
BTB and CNC homology 2 |
|
multiple interactions |
EXP |
4 |
32,504,410 |
32,673,083 |
RGD:6480464 |
CTD |
| G |
Bach2 |
BTB and CNC homology 2 |
|
affects localization |
EXP |
4 |
32,504,410 |
32,673,083 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene 1 |
|
decreases expression |
ISO |
4 |
40,883,431 |
40,895,327 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene 1 |
|
decreases expression |
EXP |
4 |
40,883,431 |
40,895,327 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene 1 |
|
multiple interactions |
ISO |
4 |
40,883,431 |
40,895,327 |
RGD:6480464 |
CTD |
| G |
Bag3 |
BCL2-associated athanogene 3 |
|
multiple interactions |
ISO |
7 |
135,667,097 |
135,690,495 |
RGD:6480464 |
CTD |
| G |
Bag3 |
BCL2-associated athanogene 3 |
|
increases expression |
ISO |
7 |
135,667,097 |
135,690,495 |
RGD:6480464 |
CTD |
| G |
Bard1 |
BRCA1 associated RING domain 1 |
|
decreases expression |
ISO |
1 |
71,074,109 |
71,149,546 |
RGD:6480464 |
CTD |
| G |
BC003965 |
cDNA sequence BC003965 |
|
increases methylation |
ISO |
17 |
25,321,506 |
25,324,607 |
RGD:6480464 |
CTD |
| G |
Bcas1 |
breast carcinoma amplified sequence 1 |
|
increases expression |
ISO |
2 |
170,172,491 |
170,253,345 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
EXP |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
decreases expression |
EXP |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bcl2l15 |
BCLl2-like 15 |
|
increases expression |
ISO |
3 |
103,636,619 |
103,658,541 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
BCL2-like 2 |
|
decreases expression |
ISO |
14 |
55,502,262 |
55,507,071 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
BCL2-like 2 |
|
increases expression |
EXP |
14 |
55,502,262 |
55,507,071 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
BCL2-like 2 |
|
decreases expression |
EXP |
14 |
55,502,262 |
55,507,071 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
EXP |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases expression |
EXP |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
decreases expression |
EXP |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
decreases expression |
ISO |
6 |
120,843,137 |
120,866,838 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
decreases expression |
ISO |
9 |
7,818,226 |
7,835,255 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
decreases expression |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Blvrb |
biliverdin reductase B (flavin reductase (NADPH)) |
|
decreases expression |
ISO |
7 |
28,232,997 |
28,251,000 |
RGD:6480464 |
CTD |
| G |
Bmi1 |
Bmi1 polycomb ring finger oncogene |
|
decreases methylation |
ISO |
2 |
18,598,645 |
18,608,256 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
2 |
133,378,935 |
133,388,621 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
increases expression |
ISO |
14 |
47,003,195 |
47,010,274 |
RGD:6480464 |
CTD |
| G |
Bmpr1a |
bone morphogenetic protein receptor, type 1A |
|
increases methylation |
ISO |
14 |
35,224,254 |
35,315,732 |
RGD:6480464 |
CTD |
| G |
Bmpr2 |
bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
increases expression |
EXP |
1 |
59,821,481 |
59,927,703 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
increases expression |
ISO |
7 |
146,082,519 |
146,101,189 |
RGD:6480464 |
CTD |
| G |
Btrc |
beta-transducin repeat containing protein |
|
decreases expression |
EXP |
19 |
45,438,224 |
45,607,833 |
RGD:6480464 |
CTD |
| G |
Cabs1 |
calcium binding protein, spermatid specific 1 |
|
increases methylation |
ISO |
5 |
88,408,476 |
88,410,566 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
multiple interactions |
ISO |
2 |
24,461,895 |
24,618,672 |
RGD:6480464 |
CTD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
increases expression |
ISO |
14 |
30,853,125 |
31,304,342 |
RGD:6480464 |
CTD |
| G |
Cacng7 |
calcium channel, voltage-dependent, gamma subunit 7 |
|
increases methylation |
ISO |
7 |
3,336,685 |
3,366,537 |
RGD:6480464 |
CTD |
| G |
Cacybp |
calcyclin binding protein |
|
decreases expression |
ISO |
1 |
162,133,052 |
162,142,908 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases methylation |
ISO |
4 |
15,808,411 |
15,833,856 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
EXP |
12 |
101,437,751 |
101,448,016 |
RGD:6480464 |
CTD |
| G |
Calr3 |
calreticulin 3 |
|
decreases methylation |
ISO |
8 |
74,948,082 |
74,967,677 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
multiple interactions |
ISO |
18 |
61,085,286 |
61,147,806 |
RGD:6480464 |
CTD |
| G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
|
decreases expression |
ISO |
14 |
21,554,097 |
21,613,310 |
RGD:6480464 |
CTD |
| G |
Camp |
cathelicidin antimicrobial peptide |
|
increases methylation |
ISO |
9 |
109,749,891 |
109,751,970 |
RGD:6480464 |
CTD |
| G |
Capg |
capping protein (actin filament), gelsolin-like |
|
affects expression |
ISO |
6 |
72,494,433 |
72,512,974 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
decreases expression |
ISO |
7 |
30,971,961 |
30,980,067 |
RGD:6480464 |
CTD |
| G |
Car7 |
carbonic anhydrase 7 |
|
increases methylation |
ISO |
8 |
107,064,707 |
107,074,243 |
RGD:6480464 |
CTD |
| G |
Carhsp1 |
calcium regulated heat stable protein 1 |
|
increases methylation |
ISO |
16 |
8,658,680 |
8,672,246 |
RGD:6480464 |
CTD |
| G |
Caskin1 |
CASK interacting protein 1 |
|
decreases methylation |
ISO |
17 |
24,625,728 |
24,645,854 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
decreases expression |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases cleavage |
EXP |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
1 |
58,852,218 |
58,904,347 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
EXP |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
EXP |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
multiple interactions |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9 |
|
increases activity |
ISO |
4 |
141,349,527 |
141,371,890 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases response to substance |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cbwd1 |
COBW domain containing 1 |
|
increases expression |
ISO |
19 |
24,994,406 |
25,036,106 |
RGD:6480464 |
CTD |
| G |
Ccdc25 |
coiled-coil domain containing 25 |
|
increases expression |
ISO |
14 |
66,456,139 |
66,485,441 |
RGD:6480464 |
CTD |
| G |
Ccdc94 |
coiled-coil domain containing 94 |
|
decreases expression |
EXP |
17 |
56,098,610 |
56,107,374 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
EXP |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
EXP |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
decreases expression |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnb1ip1 |
cyclin B1 interacting protein 1 |
|
increases expression |
ISO |
14 |
51,408,924 |
51,415,403 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
EXP |
9 |
70,255,496 |
70,269,361 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
multiple interactions |
EXP |
11 |
40,562,054 |
40,568,788 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
11 |
40,562,054 |
40,568,788 |
RGD:6480464 |
CTD |
| G |
Cct5 |
chaperonin containing Tcp1, subunit 5 (epsilon) |
|
increases expression |
ISO |
15 |
31,520,639 |
31,531,559 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 antigen |
|
increases expression |
EXP |
7 |
148,653,261 |
148,657,380 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 antigen |
|
decreases expression |
ISO |
7 |
148,653,261 |
148,657,380 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
decreases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd4 |
CD4 antigen |
|
increases expression |
ISO |
6 |
124,814,711 |
124,838,227 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
EXP |
4 |
118,105,506 |
118,109,948 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
decreases expression |
EXP |
2 |
131,012,687 |
131,024,233 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
EXP |
18 |
34,892,651 |
34,911,187 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 |
|
increases expression |
ISO |
4 |
136,875,611 |
136,913,652 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
multiple interactions |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh1 |
cadherin 1 |
|
decreases expression |
ISO |
8 |
109,127,268 |
109,194,146 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
multiple interactions |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
10 |
68,799,383 |
68,815,660 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
EXP |
10 |
126,500,659 |
126,504,339 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 (CDC2-related kinase) |
|
decreases expression |
EXP |
2 |
32,561,302 |
32,568,304 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
multiple interactions |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
EXP |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
4 |
88,920,377 |
88,940,523 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
EXP |
14 |
47,380,216 |
47,391,200 |
RGD:6480464 |
CTD |
| G |
Cdr2 |
cerebellar degeneration-related 2 |
|
affects expression |
ISO |
7 |
128,100,550 |
128,125,826 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
increases expression |
ISO |
19 |
5,490,455 |
5,494,031 |
RGD:6480464 |
CTD |
| G |
Chad |
chondroadherin |
|
decreases expression |
ISO |
11 |
94,426,388 |
94,430,441 |
RGD:6480464 |
CTD |
| G |
Chpt1 |
choline phosphotransferase 1 |
|
increases expression |
ISO |
10 |
87,935,558 |
87,966,715 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
EXP |
19 |
44,147,824 |
44,181,967 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
increases phosphorylation |
EXP |
19 |
44,147,824 |
44,181,967 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
decreases activity |
ISO |
19 |
44,147,824 |
44,181,967 |
RGD:6480464 |
CTD |
| G |
Cideb |
cell death-inducing DNA fragmentation factor, alpha subunit-like effector B |
|
decreases expression |
ISO |
14 |
56,372,889 |
56,377,261 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
ISO |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
multiple interactions |
ISO |
7 |
19,996,443 |
20,006,932 |
RGD:6480464 |
CTD |
| G |
Clgn |
calmegin |
|
decreases expression |
ISO |
8 |
85,913,790 |
85,950,728 |
RGD:6480464 |
CTD |
| G |
Clns1a |
chloride channel, nucleotide-sensitive, 1A |
|
increases expression |
ISO |
7 |
104,845,201 |
104,867,389 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
increases expression |
EXP |
14 |
122,580,916 |
122,801,456 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
multiple interactions |
ISO |
19 |
12,838,018 |
12,840,122 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
decreases expression |
ISO |
8 |
11,312,829 |
11,449,287 |
RGD:6480464 |
CTD |
| G |
Col6a2 |
collagen, type VI, alpha 2 |
|
multiple interactions |
ISO |
10 |
76,058,501 |
76,086,149 |
RGD:6480464 |
CTD |
| G |
Coq4 |
coenzyme Q4 homolog (yeast) |
|
decreases expression |
EXP |
2 |
29,643,783 |
29,653,263 |
RGD:6480464 |
CTD |
| G |
Cox19 |
cytochrome c oxidase assembly protein 19 |
|
decreases expression |
EXP |
5 |
139,813,776 |
139,821,120 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
19 |
3,323,301 |
3,385,733 |
RGD:6480464 |
CTD |
| G |
Cryab |
crystallin, alpha B |
|
multiple interactions |
ISO |
9 |
50,560,863 |
50,564,738 |
RGD:6480464 |
CTD |
| G |
Cryba4 |
crystallin, beta A4 |
|
increases expression |
ISO |
5 |
112,675,553 |
112,681,522 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
EXP |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 |
|
increases expression |
ISO |
5 |
91,320,271 |
91,322,147 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
ISO |
1 |
130,484,776 |
130,488,876 |
RGD:6480464 |
CTD |
| G |
Cyb5rl |
cytochrome b5 reductase-like |
|
decreases expression |
ISO |
4 |
106,742,773 |
106,757,410 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
6 |
50,512,562 |
50,516,473 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
9 |
57,862,824 |
57,874,830 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
9 |
57,862,824 |
57,874,830 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
19 |
46,741,655 |
46,747,490 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases activity |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases stability |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
decreases expression |
ISO |
17 |
80,106,293 |
80,114,381 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
multiple interactions |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
increases expression |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
multiple interactions |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
increases expression |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
increases expression |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
multiple interactions |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
multiple interactions |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
|
multiple interactions |
EXP |
7 |
27,620,358 |
27,628,283 |
RGD:6480464 |
CTD |
| G |
Cyp2f2 |
cytochrome P450, family 2, subfamily f, polypeptide 2 |
|
decreases expression |
EXP |
7 |
27,904,974 |
27,918,679 |
RGD:6480464 |
CTD |
| G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
|
decreases expression |
EXP |
5 |
146,666,183 |
146,691,430 |
RGD:6480464 |
CTD |
| G |
D10Jhu81e |
DNA segment, Chr 10, Johns Hopkins University 81 expressed |
|
decreases methylation |
ISO |
10 |
77,624,812 |
77,632,513 |
RGD:6480464 |
CTD |
| G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
|
multiple interactions |
ISO |
15 |
6,249,789 |
6,390,712 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
10 |
126,727,849 |
126,733,344 |
RGD:6480464 |
CTD |
| G |
Dennd6a |
DENN/MADD domain containing 6A |
|
increases expression |
ISO |
14 |
27,399,036 |
27,451,586 |
RGD:6480464 |
CTD |
| G |
Det1 |
de-etiolated homolog 1 (Arabidopsis) |
|
decreases expression |
EXP |
7 |
85,972,360 |
85,992,097 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
decreases expression |
ISO |
15 |
76,332,445 |
76,342,248 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo homolog (Drosophila) |
|
affects localization |
EXP |
5 |
123,961,339 |
123,974,173 |
RGD:6480464 |
CTD |
| G |
Dimt1 |
DIM1 dimethyladenosine transferase 1-like (S. cerevisiae) |
|
decreases expression |
EXP |
13 |
107,737,209 |
107,750,304 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
increases expression |
ISO |
12 |
32,016,427 |
32,036,302 |
RGD:6480464 |
CTD |
| G |
Dmpk |
dystrophia myotonica-protein kinase |
|
increases methylation |
ISO |
7 |
19,669,198 |
19,679,170 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
8 |
86,132,074 |
86,135,802 |
RGD:6480464 |
CTD |
| G |
Dnajb6 |
DnaJ (Hsp40) homolog, subfamily B, member 6 |
|
increases expression |
EXP |
5 |
30,062,438 |
30,113,018 |
RGD:6480464 |
CTD |
| G |
Dtx1 |
deltex 1 homolog (Drosophila) |
|
decreases expression |
ISO |
5 |
121,130,273 |
121,161,678 |
RGD:6480464 |
CTD |
| G |
Ebp |
phenylalkylamine Ca2+ antagonist (emopamil) binding protein |
|
decreases expression |
ISO |
X |
7,762,457 |
7,770,638 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
9 |
78,326,260 |
78,329,531 |
RGD:6480464 |
CTD |
| G |
EG628324 |
predicted gene, EG628324 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
increases expression |
EXP |
6 |
70,794,521 |
70,855,234 |
RGD:6480464 |
CTD |
| G |
Endog |
endonuclease G |
|
affects localization |
EXP |
2 |
30,027,044 |
30,029,589 |
RGD:6480464 |
CTD |
| G |
Epb4.1l3 |
erythrocyte protein band 4.1-like 3 |
|
multiple interactions |
ISO |
17 |
69,506,150 |
69,639,329 |
RGD:6480464 |
CTD |
| G |
Epha5 |
Eph receptor A5 |
|
multiple interactions |
ISO |
5 |
84,483,786 |
84,846,407 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
decreases expression |
EXP |
1 |
182,919,687 |
182,947,626 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
increases expression |
ISO |
1 |
182,919,687 |
182,947,626 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
decreases expression |
EXP |
14 |
66,703,214 |
66,743,337 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
decreases expression |
ISO |
5 |
137,924,248 |
137,927,044 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
multiple interactions |
ISO |
10 |
128,006,424 |
128,026,557 |
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
multiple interactions |
ISO |
7 |
19,967,388 |
19,981,041 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
1 |
44,204,589 |
44,238,105 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
increases expression |
EXP |
1 |
44,204,589 |
44,238,105 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Ets2 |
E26 avian leukemia oncogene 2, 3' domain |
|
increases expression |
ISO |
16 |
95,924,014 |
95,942,656 |
RGD:6480464 |
CTD |
| G |
F930017I19Rik |
Riken cDNA F930017I19 gene |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
increases expression |
ISO |
3 |
10,012,606 |
10,016,610 |
RGD:6480464 |
CTD |
| G |
Fam26e |
family with sequence similarity 26, member E |
|
decreases expression |
ISO |
10 |
33,811,158 |
33,816,325 |
RGD:6480464 |
CTD |
| G |
Fam98c |
family with sequence similarity 98, member C |
|
increases methylation |
ISO |
7 |
29,937,529 |
29,941,229 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
increases expression |
EXP |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily member 6) |
|
multiple interactions |
EXP |
19 |
34,365,149 |
34,402,260 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fasl |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
163,710,820 |
163,718,626 |
RGD:6480464 |
CTD |
| G |
Fastkd2 |
FAST kinase domains 2 |
|
decreases expression |
EXP |
1 |
63,777,199 |
63,799,959 |
RGD:6480464 |
CTD |
| G |
Fat1 |
FAT tumor suppressor homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
8 |
46,035,562 |
46,137,611 |
RGD:6480464 |
CTD |
| G |
Fbxo6 |
F-box protein 6 |
|
decreases expression |
EXP |
4 |
147,519,825 |
147,526,244 |
RGD:6480464 |
CTD |
| G |
Fert2 |
fer (fms/fps related) protein kinase, testis specific 2 |
|
increases expression |
ISO |
17 |
64,245,367 |
64,488,845 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
8 |
26,629,244 |
26,686,186 |
RGD:6480464 |
CTD |
| G |
Fggy |
FGGY carbohydrate kinase domain containing |
|
decreases expression |
ISO |
4 |
95,224,198 |
95,593,630 |
RGD:6480464 |
CTD |
| G |
Fh1 |
fumarate hydratase 1 |
|
decreases expression |
EXP |
1 |
177,531,509 |
177,555,766 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
19 |
5,447,698 |
5,455,938 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
ISO |
19 |
5,447,698 |
5,455,938 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
EXP |
19 |
5,447,698 |
5,455,938 |
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled homolog 6 (Drosophila) |
|
increases expression |
EXP |
15 |
38,837,826 |
38,869,738 |
RGD:6480464 |
CTD |
| G |
Fzd7 |
frizzled homolog 7 (Drosophila) |
|
increases expression |
EXP |
1 |
59,538,991 |
59,543,799 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic |
|
increases expression |
ISO |
11 |
101,229,044 |
101,239,217 |
RGD:6480464 |
CTD |
| G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
decreases activity |
ISO |
X |
71,654,825 |
71,674,500 |
RGD:6480464 |
CTD |
| G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
increases expression |
EXP |
X |
71,654,825 |
71,674,500 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
multiple interactions |
EXP |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases expression |
EXP |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
increases response to substance |
EXP |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gas1 |
growth arrest specific 1 |
|
decreases expression |
EXP |
13 |
60,275,766 |
60,278,896 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
multiple interactions |
ISO |
18 |
11,052,508 |
11,085,633 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate-cysteine ligase, modifier subunit |
|
increases expression |
EXP |
3 |
121,948,510 |
121,969,566 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
multiple interactions |
ISO |
8 |
73,153,293 |
73,155,534 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
11 |
102,748,650 |
102,758,514 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
11 |
102,748,650 |
102,758,514 |
RGD:6480464 |
CTD |
| G |
Gfod2 |
glucose-fructose oxidoreductase domain containing 2 |
|
decreases expression |
ISO |
8 |
108,240,013 |
108,282,507 |
RGD:6480464 |
CTD |
| G |
Gjb6 |
gap junction protein, beta 6 |
|
decreases expression |
ISO |
14 |
57,742,140 |
57,752,414 |
RGD:6480464 |
CTD |
| G |
Glg1 |
golgi apparatus protein 1 |
|
increases expression |
EXP |
8 |
113,681,448 |
113,783,102 |
RGD:6480464 |
CTD |
| G |
Gli1 |
GLI-Kruppel family member GLI1 |
|
multiple interactions |
ISO |
10 |
126,766,938 |
126,778,635 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin |
|
multiple interactions |
ISO |
13 |
75,977,334 |
75,987,599 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase (glutamine synthetase) |
|
increases expression |
ISO |
1 |
155,747,075 |
155,756,844 |
RGD:6480464 |
CTD |
| G |
Gm20783 |
predicted gene, 20783 |
|
affects methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gm9571 |
predicted gene 9571 |
|
decreases expression |
ISO |
7 |
112,857,038 |
112,870,313 |
RGD:6480464 |
CTD |
| G |
Gmpr |
guanosine monophosphate reductase |
|
increases expression |
ISO |
13 |
45,602,838 |
45,641,750 |
RGD:6480464 |
CTD |
| G |
Golga2 |
golgi autoantigen, golgin subfamily a, 2 |
|
increases expression |
EXP |
2 |
32,143,773 |
32,163,441 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamate oxaloacetate transaminase 1, soluble |
|
increases expression |
ISO |
19 |
43,574,242 |
43,599,095 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
increases expression |
ISO |
19 |
55,144,224 |
55,173,937 |
RGD:6480464 |
CTD |
| G |
Gpr30 |
G protein-coupled receptor 30 |
|
decreases expression |
ISO |
5 |
139,899,133 |
139,903,754 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
increases expression |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic pyruvic transaminase, soluble |
|
decreases activity |
ISO |
15 |
76,527,194 |
76,530,105 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
affects activity |
ISO |
12 |
77,893,322 |
77,896,541 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
multiple interactions |
ISO |
10 |
79,516,255 |
79,519,184 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases expression |
ISO |
10 |
79,516,255 |
79,519,184 |
RGD:6480464 |
CTD |
| G |
Gpx5 |
glutathione peroxidase 5 |
|
affects activity |
ISO |
13 |
21,378,298 |
21,384,555 |
RGD:6480464 |
CTD |
| G |
Gpx7 |
glutathione peroxidase 7 |
|
decreases expression |
EXP |
4 |
108,072,822 |
108,079,318 |
RGD:6480464 |
CTD |
| G |
Grhpr |
glyoxylate reductase/hydroxypyruvate reductase |
|
decreases expression |
ISO |
4 |
44,994,283 |
45,003,568 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
decreases expression |
ISO |
2 |
35,137,960 |
35,163,412 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases expression |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
affects activity |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase, alpha 2 (Yc2) |
|
increases expression |
EXP |
9 |
78,178,827 |
78,194,952 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
increases expression |
EXP |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase, alpha 3 |
|
increases expression |
ISO |
1 |
21,230,670 |
21,255,640 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
increases expression |
EXP |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
decreases expression |
EXP |
6 |
42,195,934 |
42,200,440 |
RGD:6480464 |
CTD |
| G |
Gtf3c2 |
general transcription factor IIIC, polypeptide 2, beta |
|
decreases expression |
EXP |
5 |
31,458,379 |
31,482,517 |
RGD:6480464 |
CTD |
| G |
Gtpbp3 |
GTP binding protein 3 |
|
decreases expression |
EXP |
8 |
74,012,002 |
74,017,299 |
RGD:6480464 |
CTD |
| G |
Gtpbp6 |
GTP binding protein 6 (putative) |
|
increases expression |
ISO |
5 |
110,532,996 |
110,537,216 |
RGD:6480464 |
CTD |
| G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
increases expression |
ISO |
17 |
34,400,172 |
34,406,363 |
RGD:6480464 |
CTD |
| G |
H2-Ke6 |
H2-K region expressed gene 6 |
|
decreases expression |
ISO |
17 |
34,162,978 |
34,165,000 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
ISO |
7 |
31,727,387 |
31,729,036 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
increases expression |
ISO |
7 |
31,727,387 |
31,729,036 |
RGD:6480464 |
CTD |
| G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
decreases expression |
ISO |
11 |
32,183,672 |
32,184,486 |
RGD:6480464 |
CTD |
| G |
Hck |
hemopoietic cell kinase |
|
multiple interactions |
ISO |
2 |
152,934,204 |
152,977,177 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
decreases expression |
ISO |
3 |
87,710,243 |
87,720,054 |
RGD:6480464 |
CTD |
| G |
Heca |
headcase homolog (Drosophila) |
|
increases expression |
EXP |
10 |
17,620,272 |
17,667,873 |
RGD:6480464 |
CTD |
| G |
Hemt1 |
hematopoietic cell transcript 1 |
|
increases expression |
EXP |
15 |
74,649,506 |
74,654,866 |
RGD:6480464 |
CTD |
| G |
Hfe |
hemochromatosis |
|
increases expression |
ISO |
13 |
23,795,710 |
23,802,680 |
RGD:6480464 |
CTD |
| G |
Hist1h2ac |
histone cluster 1, H2ac |
|
multiple interactions |
ISO |
13 |
23,773,336 |
23,775,828 |
RGD:6480464 |
CTD |
| G |
Hjurp |
Holliday junction recognition protein |
|
increases expression |
ISO |
1 |
90,155,431 |
90,174,154 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
increases expression |
ISO |
13 |
97,418,917 |
97,440,891 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hnrnph2 |
heterogeneous nuclear ribonucleoprotein H2 |
|
decreases expression |
ISO |
X |
131,135,825 |
131,141,593 |
RGD:6480464 |
CTD |
| G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
|
decreases expression |
EXP |
13 |
64,159,582 |
64,190,509 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
increases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
EXP |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
increases expression |
ISO |
11 |
53,073,316 |
53,113,981 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
EXP |
2 |
34,627,610 |
34,632,049 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
5 |
136,363,789 |
136,365,433 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105kDa/110kDa protein 1 |
|
increases expression |
EXP |
5 |
150,419,420 |
150,438,890 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
decreases expression |
EXP |
6 |
83,001,260 |
83,004,565 |
RGD:6480464 |
CTD |
| G |
Hus1 |
Hus1 homolog (S. pombe) |
|
decreases expression |
EXP |
11 |
8,893,145 |
8,911,140 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
multiple interactions |
ISO |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
ISO |
12 |
25,778,664 |
25,780,957 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ifitm2 |
interferon induced transmembrane protein 2 |
|
increases expression |
ISO |
7 |
148,140,738 |
148,141,860 |
RGD:6480464 |
CTD |
| G |
Ifitm3 |
interferon induced transmembrane protein 3 |
|
decreases expression |
ISO |
7 |
148,195,489 |
148,196,643 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifrd2 |
interferon-related developmental regulator 2 |
|
decreases expression |
EXP |
9 |
107,490,049 |
107,495,369 |
RGD:6480464 |
CTD |
| G |
Igf2r |
insulin-like growth factor 2 receptor |
|
increases expression |
ISO |
17 |
12,875,272 |
12,962,572 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
ISO |
1 |
72,904,639 |
72,921,439 |
RGD:6480464 |
CTD |
| G |
Igfbp7 |
insulin-like growth factor binding protein 7 |
|
multiple interactions |
ISO |
5 |
77,778,265 |
77,837,070 |
RGD:6480464 |
CTD |
| G |
Iigp1 |
interferon inducible GTPase 1 |
|
decreases expression |
EXP |
18 |
60,535,683 |
60,552,288 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappaB kinase beta |
|
multiple interactions |
EXP |
8 |
23,769,677 |
23,817,055 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappaB kinase beta |
|
increases phosphorylation |
EXP |
8 |
23,769,677 |
23,817,055 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1rn |
interleukin 1 receptor antagonist |
|
decreases expression |
EXP |
2 |
24,192,380 |
24,207,011 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Ilk |
integrin linked kinase |
|
increases expression |
ISO |
7 |
112,885,104 |
112,891,439 |
RGD:6480464 |
CTD |
| G |
Inadl |
InaD-like (Drosophila) |
|
affects expression |
ISO |
4 |
98,062,517 |
98,386,294 |
RGD:6480464 |
CTD |
| G |
Inadl |
InaD-like (Drosophila) |
|
affects expression |
ISO |
4 |
98,062,517 |
98,386,294 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin beta 4 |
|
multiple interactions |
ISO |
11 |
115,836,039 |
115,869,725 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
decreases expression |
ISO |
3 |
92,374,824 |
92,377,637 |
RGD:6480464 |
CTD |
| G |
Jagn1 |
jagunal homolog 1 (Drosophila) |
|
decreases expression |
EXP |
6 |
113,392,629 |
113,398,221 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases phosphorylation |
EXP |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases expression |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Junb |
Jun-B oncogene |
|
multiple interactions |
ISO |
8 |
87,500,811 |
87,502,617 |
RGD:6480464 |
CTD |
| G |
Junb |
Jun-B oncogene |
|
increases expression |
EXP |
8 |
87,500,811 |
87,502,617 |
RGD:6480464 |
CTD |
| G |
Kcnj2 |
potassium inwardly-rectifying channel, subfamily J, member 2 |
|
decreases expression |
ISO |
11 |
110,927,478 |
110,938,139 |
RGD:6480464 |
CTD |
| G |
Keap1 |
kelch-like ECH-associated protein 1 |
|
affects binding |
EXP |
9 |
21,034,174 |
21,043,776 |
RGD:6480464 |
CTD |
| G |
Keap1 |
kelch-like ECH-associated protein 1 |
|
decreases expression |
EXP |
9 |
21,034,174 |
21,043,776 |
RGD:6480464 |
CTD |
| G |
Klhl24 |
kelch-like 24 |
|
increases expression |
EXP |
16 |
20,097,627 |
20,127,817 |
RGD:6480464 |
CTD |
| G |
Krt16 |
keratin 16 |
|
decreases expression |
ISO |
11 |
100,107,405 |
100,110,216 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
increases expression |
ISO |
16 |
19,653,474 |
19,706,458 |
RGD:6480464 |
CTD |
| G |
Lce3b |
late cornified envelope 3B |
|
decreases expression |
ISO |
3 |
92,736,901 |
92,738,018 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
2 |
32,240,157 |
32,243,259 |
RGD:6480464 |
CTD |
| G |
Lcn8 |
lipocalin 8 |
|
increases expression |
ISO |
2 |
25,508,638 |
25,511,737 |
RGD:6480464 |
CTD |
| G |
Ldb3 |
LIM domain binding 3 |
|
increases methylation |
ISO |
14 |
35,339,885 |
35,401,867 |
RGD:6480464 |
CTD |
| G |
Ldhc |
lactate dehydrogenase C |
|
decreases activity |
ISO |
7 |
54,116,633 |
54,133,512 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
ISO |
17 |
89,140,889 |
89,191,316 |
RGD:6480464 |
CTD |
| G |
Lin28a |
lin-28 homolog A (C. elegans) |
|
increases expression |
ISO |
4 |
133,559,245 |
133,574,731 |
RGD:6480464 |
CTD |
| G |
Lnpep |
leucyl/cystinyl aminopeptidase |
|
increases expression |
EXP |
17 |
17,664,687 |
17,761,453 |
RGD:6480464 |
CTD |
| G |
Lnx1 |
ligand of numb-protein X 1 |
|
increases expression |
EXP |
5 |
74,988,472 |
75,098,928 |
RGD:6480464 |
CTD |
| G |
Lonrf1 |
LON peptidase N-terminal domain and ring finger 1 |
|
decreases expression |
ISO |
8 |
37,279,118 |
37,312,570 |
RGD:6480464 |
CTD |
| G |
Lrpap1 |
low density lipoprotein receptor-related protein associated protein 1 |
|
multiple interactions |
ISO |
5 |
35,434,155 |
35,448,346 |
RGD:6480464 |
CTD |
| G |
Ly96 |
lymphocyte antigen 96 |
|
increases methylation |
ISO |
1 |
16,678,537 |
16,699,686 |
RGD:6480464 |
CTD |
| G |
Lyrm2 |
LYR motif containing 2 |
|
increases methylation |
ISO |
4 |
32,887,234 |
32,889,243 |
RGD:6480464 |
CTD |
| G |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
|
decreases expression |
ISO |
9 |
75,473,539 |
75,485,580 |
RGD:6480464 |
CTD |
| G |
Maf |
avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog |
|
increases expression |
EXP |
8 |
118,227,153 |
118,230,794 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
|
increases expression |
EXP |
15 |
79,178,108 |
79,189,506 |
RGD:6480464 |
CTD |
| G |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
|
increases expression |
ISO |
11 |
120,489,662 |
120,494,861 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
|
increases expression |
EXP |
5 |
140,267,490 |
140,278,606 |
RGD:6480464 |
CTD |
| G |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
|
increases expression |
ISO |
5 |
140,267,490 |
140,278,606 |
RGD:6480464 |
CTD |
| G |
Magee1 |
melanoma antigen, family E, 1 |
|
decreases expression |
ISO |
X |
102,315,735 |
102,319,251 |
RGD:6480464 |
CTD |
| G |
Maml1 |
mastermind like 1 (Drosophila) |
|
increases methylation |
ISO |
11 |
50,069,136 |
50,105,838 |
RGD:6480464 |
CTD |
| G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
multiple interactions |
EXP |
8 |
124,114,368 |
124,121,947 |
RGD:6480464 |
CTD |
| G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
increases expression |
EXP |
8 |
124,114,368 |
124,121,947 |
RGD:6480464 |
CTD |
| G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
|
increases expression |
ISO |
8 |
124,114,368 |
124,121,947 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
multiple interactions |
ISO |
11 |
110,260,436 |
110,374,951 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
10 |
19,654,332 |
19,862,556 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases phosphorylation |
ISO |
10 |
19,654,332 |
19,862,556 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases activity |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen-activated protein kinase 10 |
|
decreases methylation |
ISO |
5 |
103,336,967 |
103,640,353 |
RGD:6480464 |
CTD |
| G |
Mapk11 |
mitogen-activated protein kinase 11 |
|
multiple interactions |
ISO |
15 |
88,972,912 |
88,980,036 |
RGD:6480464 |
CTD |
| G |
Mapk12 |
mitogen-activated protein kinase 12 |
|
decreases expression |
ISO |
15 |
88,961,014 |
88,971,133 |
RGD:6480464 |
CTD |
| G |
Mapk12 |
mitogen-activated protein kinase 12 |
|
multiple interactions |
EXP |
15 |
88,961,014 |
88,971,133 |
RGD:6480464 |
CTD |
| G |
Mapk12 |
mitogen-activated protein kinase 12 |
|
increases expression |
ISO |
15 |
88,961,014 |
88,971,133 |
RGD:6480464 |
CTD |
| G |
Mapk13 |
mitogen-activated protein kinase 13 |
|
multiple interactions |
ISO |
17 |
28,906,262 |
28,915,649 |
RGD:6480464 |
CTD |
| G |
Mapk13 |
mitogen-activated protein kinase 13 |
|
decreases methylation |
ISO |
17 |
28,906,262 |
28,915,649 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk4 |
mitogen-activated protein kinase 4 |
|
multiple interactions |
ISO |
18 |
74,088,140 |
74,224,603 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
EXP |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
|
affects expression |
EXP |
2 |
92,223,837 |
92,241,420 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
EXP |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
11 |
49,660,253 |
49,699,923 |
RGD:6480464 |
CTD |
| G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
|
increases expression |
EXP |
2 |
153,567,023 |
153,599,053 |
RGD:6480464 |
CTD |
| G |
Mat1a |
methionine adenosyltransferase I, alpha |
|
decreases methylation |
ISO |
14 |
41,918,670 |
41,937,701 |
RGD:6480464 |
CTD |
| G |
Matk |
megakaryocyte-associated tyrosine kinase |
|
multiple interactions |
ISO |
10 |
80,720,290 |
80,725,726 |
RGD:6480464 |
CTD |
| G |
Mcf2 |
mcf.2 transforming sequence |
|
multiple interactions |
ISO |
X |
57,309,133 |
57,400,820 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
increases expression |
ISO |
3 |
95,462,643 |
95,467,102 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance deficient 2 mitotin (S. cerevisiae) |
|
increases expression |
ISO |
6 |
88,833,468 |
88,848,774 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) |
|
decreases expression |
ISO |
8 |
77,633,427 |
77,652,338 |
RGD:6480464 |
CTD |
| G |
Mcph1 |
microcephaly, primary autosomal recessive 1 |
|
increases expression |
ISO |
8 |
18,595,173 |
18,803,189 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
increases phosphorylation |
EXP |
10 |
117,125,961 |
117,147,772 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
increases expression |
EXP |
10 |
117,125,961 |
117,147,772 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
increases expression |
EXP |
10 |
117,125,961 |
117,147,772 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
transformed mouse 3T3 cell double minute 2 |
|
affects expression |
ISO |
10 |
117,125,961 |
117,147,772 |
RGD:6480464 |
CTD |
| G |
Med16 |
mediator complex subunit 16 |
|
increases methylation |
ISO |
10 |
79,357,452 |
79,371,683 |
RGD:6480464 |
CTD |
| G |
Med18 |
mediator of RNA polymerase II transcription, subunit 18 homolog (yeast) |
|
decreases expression |
ISO |
4 |
132,014,644 |
132,019,836 |
RGD:6480464 |
CTD |
| G |
Med26 |
mediator complex subunit 26 |
|
decreases methylation |
ISO |
8 |
75,018,457 |
75,072,209 |
RGD:6480464 |
CTD |
| G |
Med27 |
mediator complex subunit 27 |
|
increases methylation |
ISO |
2 |
29,202,356 |
29,380,308 |
RGD:6480464 |
CTD |
| G |
Mef2b |
myocyte enhancer factor 2B |
|
decreases methylation |
ISO |
8 |
72,676,677 |
72,691,387 |
RGD:6480464 |
CTD |
| G |
Melk |
maternal embryonic leucine zipper kinase |
|
increases methylation |
ISO |
4 |
44,313,789 |
44,377,547 |
RGD:6480464 |
CTD |
| G |
Mettl25 |
methyltransferase like 25 |
|
increases expression |
ISO |
10 |
105,200,241 |
105,278,436 |
RGD:6480464 |
CTD |
| G |
Mfsd7a |
major facilitator superfamily domain containing 7A |
|
increases expression |
ISO |
5 |
108,870,073 |
108,877,910 |
RGD:6480464 |
CTD |
| G |
Mgat2 |
mannoside acetylglucosaminyltransferase 2 |
|
decreases expression |
ISO |
12 |
70,285,145 |
70,287,760 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
ISO |
6 |
136,820,956 |
136,824,326 |
RGD:6480464 |
CTD |
| G |
Mgrn1 |
mahogunin, ring finger 1 |
|
decreases expression |
EXP |
16 |
4,886,252 |
4,938,296 |
RGD:6480464 |
CTD |
| G |
Micu1 |
mitochondrial calcium uptake 1 |
|
increases expression |
ISO |
10 |
59,165,383 |
59,326,871 |
RGD:6480464 |
CTD |
| G |
Mip |
major intrinsic protein of eye lens fiber |
|
decreases methylation |
ISO |
10 |
127,662,894 |
127,668,867 |
RGD:6480464 |
CTD |
| G |
Mkrn1 |
makorin, ring finger protein, 1 |
|
increases expression |
EXP |
6 |
39,347,820 |
39,370,368 |
RGD:6480464 |
CTD |
| G |
Mmachc |
methylmalonic aciduria cblC type, with homocystinuria |
|
decreases expression |
EXP |
4 |
116,375,039 |
116,380,990 |
RGD:6480464 |
CTD |
| G |
Mocs2 |
molybdenum cofactor synthesis 2 |
|
affects expression |
EXP |
13 |
115,608,445 |
115,619,628 |
RGD:6480464 |
CTD |
| G |
Mrpl19 |
mitochondrial ribosomal protein L19 |
|
decreases expression |
EXP |
6 |
81,907,820 |
81,915,943 |
RGD:6480464 |
CTD |
| G |
Mrpl28 |
mitochondrial ribosomal protein L28 |
|
decreases expression |
ISO |
17 |
26,260,448 |
26,263,558 |
RGD:6480464 |
CTD |
| G |
Mrpl3 |
mitochondrial ribosomal protein L3 |
|
increases expression |
ISO |
9 |
104,955,598 |
104,979,806 |
RGD:6480464 |
CTD |
| G |
Mrpl30 |
mitochondrial ribosomal protein L30 |
|
decreases methylation |
ISO |
1 |
37,947,398 |
37,955,178 |
RGD:6480464 |
CTD |
| G |
Mrps16 |
mitochondrial ribosomal protein S16 |
|
decreases methylation |
ISO |
14 |
21,210,453 |
21,212,777 |
RGD:6480464 |
CTD |
| G |
Mrps18b |
mitochondrial ribosomal protein S18B |
|
decreases methylation |
ISO |
17 |
36,047,330 |
36,053,314 |
RGD:6480464 |
CTD |
| G |
Mrps23 |
mitochondrial ribosomal protein S23 |
|
decreases expression |
EXP |
11 |
88,017,920 |
88,025,009 |
RGD:6480464 |
CTD |
| G |
Mrps25 |
mitochondrial ribosomal protein S25 |
|
decreases expression |
EXP |
6 |
92,119,506 |
92,134,017 |
RGD:6480464 |
CTD |
| G |
Mrps34 |
mitochondrial ribosomal protein S34 |
|
decreases methylation |
ISO |
17 |
25,032,065 |
25,033,219 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
multiple interactions |
ISO |
17 |
88,071,897 |
88,123,053 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
decreases response to substance |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases response to substance |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
decreases response to substance |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
affects expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
affects metabolic processing |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
decreases response to substance |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases response to substance |
EXP |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
decreases response to substance |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
decreases response to substance |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
multiple interactions |
ISO |
8 |
96,676,507 |
96,678,048 |
RGD:6480464 |
CTD |
| G |
Mthfs |
5, 10-methenyltetrahydrofolate synthetase |
|
decreases expression |
ISO |
9 |
89,106,028 |
89,135,063 |
RGD:6480464 |
CTD |
| G |
Mtl5 |
metallothionein-like 5, testis-specific (tesmin) |
|
decreases expression |
ISO |
19 |
3,388,869 |
3,407,785 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Mycn |
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) |
|
multiple interactions |
ISO |
12 |
12,942,899 |
12,948,642 |
RGD:6480464 |
CTD |
| G |
Myl1 |
myosin, light polypeptide 1 |
|
decreases expression |
ISO |
1 |
66,970,869 |
66,991,630 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyl transferase 1 |
|
multiple interactions |
ISO |
8 |
70,014,657 |
70,016,003 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyl transferase 1 |
|
decreases activity |
EXP |
8 |
70,014,657 |
70,016,003 |
RGD:6480464 |
CTD |
| G |
Nat1 |
N-acetyl transferase 1 |
|
multiple interactions |
EXP |
8 |
70,014,657 |
70,016,003 |
RGD:6480464 |
CTD |
| G |
Nat2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
|
multiple interactions |
ISO |
8 |
70,018,774 |
70,026,479 |
RGD:6480464 |
CTD |
| G |
Ncs1 |
neuronal calcium sensor 1 |
|
increases expression |
ISO |
2 |
31,101,443 |
31,150,992 |
RGD:6480464 |
CTD |
| G |
Ndel1 |
nuclear distribution gene E-like homolog 1 (A. nidulans) |
|
decreases expression |
ISO |
11 |
68,634,936 |
68,666,633 |
RGD:6480464 |
CTD |
| G |
Ndst2 |
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
|
decreases methylation |
ISO |
14 |
21,542,952 |
21,553,784 |
RGD:6480464 |
CTD |
| G |
Ndufa11 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 11 |
|
increases methylation |
ISO |
17 |
56,857,185 |
56,863,671 |
RGD:6480464 |
CTD |
| G |
Ndufaf4 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 4 |
|
increases methylation |
ISO |
4 |
24,825,230 |
24,832,148 |
RGD:6480464 |
CTD |
| G |
Ndufb6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 |
|
increases methylation |
ISO |
4 |
40,217,696 |
40,226,401 |
RGD:6480464 |
CTD |
| G |
Ndufb7 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 |
|
decreases expression |
ISO |
8 |
86,090,657 |
86,095,522 |
RGD:6480464 |
CTD |
| G |
Necab1 |
N-terminal EF-hand calcium binding protein 1 |
|
increases methylation |
ISO |
4 |
14,879,392 |
15,076,278 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated gene 4-like |
|
increases expression |
EXP |
18 |
65,047,410 |
65,377,480 |
RGD:6480464 |
CTD |
| G |
Nedd9 |
neural precursor cell expressed, developmentally down-regulated gene 9 |
|
affects expression |
ISO |
13 |
41,405,285 |
41,582,689 |
RGD:6480464 |
CTD |
| G |
Neurod4 |
neurogenic differentiation 4 |
|
decreases methylation |
ISO |
10 |
129,705,208 |
129,717,296 |
RGD:6480464 |
CTD |
| G |
Neurog1 |
neurogenin 1 |
|
decreases methylation |
ISO |
13 |
56,351,853 |
56,353,524 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects localization |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases localization |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects localization |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects ubiquitination |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
2 |
75,513,576 |
75,542,698 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X |
|
multiple interactions |
ISO |
8 |
87,231,498 |
87,324,239 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
increases expression |
EXP |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
multiple interactions |
EXP |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
EXP |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
decreases phosphorylation |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nisch |
nischarin |
|
affects expression |
EXP |
14 |
31,984,114 |
32,020,012 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
5 |
118,317,128 |
118,403,822 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
affects expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Npc2 |
Niemann Pick type C2 |
|
increases expression |
EXP |
12 |
86,095,509 |
86,114,062 |
RGD:6480464 |
CTD |
| G |
Nppb |
natriuretic peptide type B |
|
increases expression |
EXP |
4 |
147,359,898 |
147,361,314 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases activity |
EXP |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
8 |
109,912,125 |
109,927,105 |
RGD:6480464 |
CTD |
| G |
Nsmf |
NMDA receptor synaptonuclear signaling and neuronal migration factor |
|
increases methylation |
ISO |
2 |
24,909,899 |
24,918,401 |
RGD:6480464 |
CTD |
| G |
Nthl1 |
nth (endonuclease III)-like 1 (E.coli) |
|
multiple interactions |
ISO |
17 |
24,769,627 |
24,775,783 |
RGD:6480464 |
CTD |
| G |
Nucb1 |
nucleobindin 1 |
|
increases expression |
EXP |
7 |
52,748,044 |
52,765,778 |
RGD:6480464 |
CTD |
| G |
Nucb2 |
nucleobindin 2 |
|
decreases expression |
ISO |
7 |
123,647,888 |
123,684,102 |
RGD:6480464 |
CTD |
| G |
Nudt18 |
nudix (nucleoside diphosphate linked moiety X)-type motif 18 |
|
increases expression |
ISO |
14 |
70,977,654 |
70,982,378 |
RGD:6480464 |
CTD |
| G |
Nuf2 |
NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae) |
|
decreases expression |
EXP |
1 |
171,428,065 |
171,461,595 |
RGD:6480464 |
CTD |
| G |
Nup153 |
nucleoporin 153 |
|
decreases methylation |
ISO |
13 |
46,775,271 |
46,823,218 |
RGD:6480464 |
CTD |
| G |
Nup210 |
nucleoporin 210 |
|
decreases expression |
ISO |
6 |
90,963,061 |
91,066,820 |
RGD:6480464 |
CTD |
| G |
Nup54 |
nucleoporin 54 |
|
increases methylation |
ISO |
5 |
92,844,566 |
92,864,225 |
RGD:6480464 |
CTD |
| G |
Nup98 |
nucleoporin 98 |
|
decreases expression |
ISO |
7 |
109,282,717 |
109,358,634 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein transcription regulator 1 |
|
increases methylation |
ISO |
7 |
133,766,760 |
133,768,984 |
RGD:6480464 |
CTD |
| G |
Nxnl2 |
nucleoredoxin-like 2 |
|
decreases methylation |
ISO |
13 |
51,266,394 |
51,270,556 |
RGD:6480464 |
CTD |
| G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
|
increases methylation |
ISO |
5 |
121,180,342 |
121,199,857 |
RGD:6480464 |
CTD |
| G |
Oasl2 |
2'-5' oligoadenylate synthetase-like 2 |
|
decreases expression |
EXP |
5 |
115,346,943 |
115,362,254 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
affects expression |
ISO |
7 |
139,749,158 |
139,768,081 |
RGD:6480464 |
CTD |
| G |
Oat |
ornithine aminotransferase |
|
increases expression |
ISO |
7 |
139,749,158 |
139,768,081 |
RGD:6480464 |
CTD |
| G |
Oaz1 |
ornithine decarboxylase antizyme 1 |
|
increases methylation |
ISO |
10 |
80,289,401 |
80,292,035 |
RGD:6480464 |
CTD |
| G |
Obp2b |
odorant binding protein 2B |
|
decreases methylation |
ISO |
2 |
25,592,529 |
25,595,617 |
RGD:6480464 |
CTD |
| G |
Oca2 |
oculocutaneous albinism II |
|
increases expression |
ISO |
7 |
63,495,141 |
63,791,887 |
RGD:6480464 |
CTD |
| G |
Olfr125 |
olfactory receptor 125 |
|
decreases methylation |
ISO |
17 |
37,971,856 |
37,972,973 |
RGD:6480464 |
CTD |
| G |
Olfr129 |
olfactory receptor 129 |
|
decreases methylation |
ISO |
17 |
38,191,544 |
38,192,536 |
RGD:6480464 |
CTD |
| G |
Olfr132 |
olfactory receptor 132 |
|
decreases methylation |
ISO |
17 |
38,267,194 |
38,268,135 |
RGD:6480464 |
CTD |
| G |
Olfr133 |
olfactory receptor 133 |
|
decreases methylation |
ISO |
17 |
38,285,535 |
38,286,473 |
RGD:6480464 |
CTD |
| G |
Olfr137 |
olfactory receptor 137 |
|
decreases methylation |
ISO |
17 |
38,441,466 |
38,442,404 |
RGD:6480464 |
CTD |
| G |
Olfr138 |
olfactory receptor 138 |
|
decreases methylation |
ISO |
17 |
38,411,718 |
38,412,656 |
RGD:6480464 |
CTD |
| G |
Olfr222 |
olfactory receptor 222 |
|
decreases expression |
ISO |
11 |
59,384,284 |
59,385,240 |
RGD:6480464 |
CTD |
| G |
Olfr412 |
olfactory receptor 412 |
|
decreases expression |
ISO |
11 |
74,178,173 |
74,179,111 |
RGD:6480464 |
CTD |
| G |
Olfr429 |
olfactory receptor 429 |
|
decreases methylation |
ISO |
1 |
176,019,169 |
176,020,111 |
RGD:6480464 |
CTD |
| G |
Olfr569 |
olfactory receptor 569 |
|
increases expression |
ISO |
7 |
110,035,721 |
110,036,665 |
RGD:6480464 |
CTD |
| G |
Olfr669 |
olfactory receptor 669 |
|
affects methylation |
ISO |
7 |
112,087,042 |
112,087,995 |
RGD:6480464 |
CTD |
| G |
Olfr720 |
olfactory receptor 720 |
|
decreases methylation |
ISO |
14 |
15,007,644 |
15,008,594 |
RGD:6480464 |
CTD |
| G |
Olfr761 |
olfactory receptor 761 |
|
decreases methylation |
ISO |
17 |
38,088,996 |
38,089,967 |
RGD:6480464 |
CTD |
| G |
Os9 |
amplified in osteosarcoma |
|
decreases expression |
ISO |
10 |
126,531,315 |
126,558,216 |
RGD:6480464 |
CTD |
| G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
|
increases expression |
EXP |
8 |
121,961,062 |
121,970,156 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
EXP |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
increases cleavage |
EXP |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha isoform |
|
increases expression |
ISO |
16 |
32,431,007 |
32,475,151 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet derived growth factor, alpha |
|
increases expression |
ISO |
5 |
139,452,925 |
139,470,907 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet derived growth factor, alpha |
|
multiple interactions |
ISO |
5 |
139,452,925 |
139,470,907 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
increases phosphorylation |
ISO |
5 |
75,548,316 |
75,594,229 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
multiple interactions |
ISO |
5 |
75,548,316 |
75,594,229 |
RGD:6480464 |
CTD |
| G |
Pdia2 |
protein disulfide isomerase associated 2 |
|
decreases expression |
ISO |
17 |
26,332,944 |
26,336,032 |
RGD:6480464 |
CTD |
| G |
Pecr |
peroxisomal trans-2-enoyl-CoA reductase |
|
increases expression |
ISO |
1 |
72,305,746 |
72,330,888 |
RGD:6480464 |
CTD |
| G |
Pfdn1 |
prefoldin 1 |
|
increases expression |
ISO |
18 |
36,563,333 |
36,614,149 |
RGD:6480464 |
CTD |
| G |
Pgc |
progastricsin (pepsinogen C) |
|
decreases expression |
ISO |
17 |
47,863,791 |
47,871,427 |
RGD:6480464 |
CTD |
| G |
Pgls |
6-phosphogluconolactonase |
|
decreases methylation |
ISO |
8 |
74,116,083 |
74,120,166 |
RGD:6480464 |
CTD |
| G |
Pglyrp4 |
peptidoglycan recognition protein 4 |
|
increases expression |
ISO |
3 |
90,530,828 |
90,545,439 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Phactr2 |
phosphatase and actin regulator 2 |
|
decreases expression |
ISO |
10 |
12,933,201 |
13,043,966 |
RGD:6480464 |
CTD |
| G |
Phactr2 |
phosphatase and actin regulator 2 |
|
decreases methylation |
ISO |
10 |
12,933,201 |
13,043,966 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
decreases expression |
ISO |
11 |
95,528,271 |
95,542,087 |
RGD:6480464 |
CTD |
| G |
Phf19 |
PHD finger protein 19 |
|
increases methylation |
ISO |
2 |
34,749,275 |
34,769,496 |
RGD:6480464 |
CTD |
| G |
Phgdh |
3-phosphoglycerate dehydrogenase |
|
decreases expression |
ISO |
3 |
98,117,094 |
98,143,892 |
RGD:6480464 |
CTD |
| G |
Phpt1 |
phosphohistidine phosphatase 1 |
|
affects methylation |
ISO |
2 |
25,428,951 |
25,430,391 |
RGD:6480464 |
CTD |
| G |
Phyhd1 |
phytanoyl-CoA dioxygenase domain containing 1 |
|
increases methylation |
ISO |
2 |
30,122,069 |
30,137,668 |
RGD:6480464 |
CTD |
| G |
Pi15 |
peptidase inhibitor 15 |
|
decreases methylation |
ISO |
1 |
17,591,982 |
17,621,020 |
RGD:6480464 |
CTD |
| G |
Pi4k2b |
phosphatidylinositol 4-kinase type 2 beta |
|
increases expression |
EXP |
5 |
53,132,813 |
53,160,579 |
RGD:6480464 |
CTD |
| G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
affects expression |
ISO |
X |
160,857,719 |
160,871,847 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
decreases methylation |
ISO |
1 |
163,899,319 |
163,903,566 |
RGD:6480464 |
CTD |
| G |
Pigq |
phosphatidylinositol glycan anchor biosynthesis, class Q |
|
increases methylation |
ISO |
17 |
26,063,369 |
26,078,907 |
RGD:6480464 |
CTD |
| G |
Pik3ap1 |
phosphoinositide-3-kinase adaptor protein 1 |
|
increases methylation |
ISO |
19 |
41,348,708 |
41,459,560 |
RGD:6480464 |
CTD |
| G |
Pik3c2g |
phosphatidylinositol 3-kinase, C2 domain containing, gamma polypeptide |
|
affects expression |
ISO |
6 |
139,664,380 |
139,917,805 |
RGD:6480464 |
CTD |
| G |
Pim1 |
proviral integration site 1 |
|
decreases methylation |
ISO |
17 |
29,627,990 |
29,632,410 |
RGD:6480464 |
CTD |
| G |
Pink1 |
PTEN induced putative kinase 1 |
|
increases expression |
EXP |
4 |
137,869,324 |
137,882,211 |
RGD:6480464 |
CTD |
| G |
Pip5k1b |
phosphatidylinositol-4-phosphate 5-kinase, type 1 beta |
|
multiple interactions |
ISO |
19 |
24,369,286 |
24,630,317 |
RGD:6480464 |
CTD |
| G |
Pisd |
phosphatidylserine decarboxylase |
|
decreases expression |
ISO |
5 |
33,078,962 |
33,128,275 |
RGD:6480464 |
CTD |
| G |
Pitx1 |
paired-like homeodomain transcription factor 1 |
|
decreases methylation |
ISO |
13 |
55,926,415 |
55,932,786 |
RGD:6480464 |
CTD |
| G |
Pkdrej |
polycystic kidney disease (polycystin) and REJ (sperm receptor for egg jelly homolog, sea urchin) |
|
increases methylation |
ISO |
15 |
85,645,106 |
85,652,163 |
RGD:6480464 |
CTD |
| G |
Pla2g10 |
phospholipase A2, group X |
|
increases methylation |
ISO |
16 |
13,715,155 |
13,730,678 |
RGD:6480464 |
CTD |
| G |
Pla2g12b |
phospholipase A2, group XIIB |
|
increases expression |
ISO |
10 |
58,866,433 |
58,884,724 |
RGD:6480464 |
CTD |
| G |
Pla2g3 |
phospholipase A2, group III |
|
decreases methylation |
ISO |
11 |
3,388,230 |
3,394,169 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
increases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
EXP |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Polr1b |
polymerase (RNA) I polypeptide B |
|
decreases expression |
EXP |
2 |
128,926,732 |
128,952,331 |
RGD:6480464 |
CTD |
| G |
Polr3e |
polymerase (RNA) III (DNA directed) polypeptide E |
|
decreases expression |
EXP |
7 |
128,061,258 |
128,090,946 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
increases expression |
ISO |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppbp |
pro-platelet basic protein |
|
increases expression |
ISO |
5 |
91,197,544 |
91,199,086 |
RGD:6480464 |
CTD |
| G |
Ppia |
peptidylprolyl isomerase A |
|
increases expression |
ISO |
11 |
6,315,873 |
6,319,813 |
RGD:6480464 |
CTD |
| G |
Pprc1 |
peroxisome proliferative activated receptor, gamma, coactivator-related 1 |
|
decreases expression |
EXP |
19 |
46,131,029 |
46,147,399 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
4 |
116,358,204 |
116,372,605 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
EXP |
4 |
116,358,204 |
116,372,605 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
4 |
116,358,204 |
116,372,605 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
4 |
116,358,204 |
116,372,605 |
RGD:6480464 |
CTD |
| G |
Prdx6 |
peroxiredoxin 6 |
|
increases expression |
ISO |
1 |
163,170,243 |
163,181,297 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases expression |
ISO |
2 |
131,735,664 |
131,764,167 |
RGD:6480464 |
CTD |
| G |
Psmd6 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
increases expression |
ISO |
14 |
14,944,699 |
14,953,418 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) 28 subunit, alpha |
|
decreases expression |
EXP |
14 |
56,197,331 |
56,200,364 |
RGD:6480464 |
CTD |
| G |
Psme2 |
proteasome (prosome, macropain) 28 subunit, beta |
|
decreases expression |
EXP |
14 |
56,206,277 |
56,209,938 |
RGD:6480464 |
CTD |
| G |
Psph |
phosphoserine phosphatase |
|
decreases expression |
ISO |
5 |
130,271,434 |
130,293,129 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
decreases expression |
EXP |
2 |
32,251,410 |
32,258,260 |
RGD:6480464 |
CTD |
| G |
Ptgfr |
prostaglandin F receptor |
|
decreases expression |
EXP |
3 |
151,461,574 |
151,500,492 |
RGD:6480464 |
CTD |
| G |
Ptms |
parathymosin |
|
increases expression |
ISO |
6 |
124,863,693 |
124,867,964 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase 4a1 |
|
multiple interactions |
ISO |
1 |
30,997,148 |
31,006,600 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming gene 1 |
|
increases expression |
ISO |
11 |
43,233,750 |
43,239,750 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming gene 1 |
|
multiple interactions |
EXP |
11 |
43,233,750 |
43,239,750 |
RGD:6480464 |
CTD |
| G |
Pwp1 |
PWP1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
85,334,576 |
85,351,848 |
RGD:6480464 |
CTD |
| G |
Pwp2 |
PWP2 periodic tryptophan protein homolog (yeast) |
|
decreases methylation |
ISO |
10 |
77,633,655 |
77,647,894 |
RGD:6480464 |
CTD |
| G |
Pxdc1 |
PX domain containing 1 |
|
decreases methylation |
ISO |
13 |
34,719,710 |
34,744,550 |
RGD:6480464 |
CTD |
| G |
Pycr1 |
pyrroline-5-carboxylate reductase 1 |
|
decreases methylation |
ISO |
11 |
120,497,026 |
120,504,984 |
RGD:6480464 |
CTD |
| G |
Pzp |
pregnancy zone protein |
|
affects expression |
ISO |
6 |
128,433,585 |
128,476,738 |
RGD:6480464 |
CTD |
| G |
Qars |
glutaminyl-tRNA synthetase |
|
increases methylation |
ISO |
9 |
108,410,336 |
108,418,272 |
RGD:6480464 |
CTD |
| G |
Qsox2 |
quiescin Q6 sulfhydryl oxidase 2 |
|
increases methylation |
ISO |
2 |
26,064,650 |
26,092,940 |
RGD:6480464 |
CTD |
| G |
R3hdm4 |
R3H domain containing 4 |
|
decreases expression |
ISO |
10 |
79,372,798 |
79,379,675 |
RGD:6480464 |
CTD |
| G |
Rab2a |
RAB2A, member RAS oncogene family |
|
increases methylation |
ISO |
4 |
8,462,791 |
8,534,849 |
RGD:6480464 |
CTD |
| G |
Rab36 |
RAB36, member RAS oncogene family |
|
decreases methylation |
ISO |
10 |
74,499,834 |
74,516,845 |
RGD:6480464 |
CTD |
| G |
Rab5b |
RAB5B, member RAS oncogene family |
|
increases methylation |
ISO |
10 |
128,114,235 |
128,133,324 |
RGD:6480464 |
CTD |
| G |
Rab6b |
RAB6B, member RAS oncogene family |
|
increases expression |
ISO |
9 |
103,014,404 |
103,087,600 |
RGD:6480464 |
CTD |
| G |
Rabgap1l |
RAB GTPase activating protein 1-like |
|
increases expression |
EXP |
1 |
162,149,305 |
162,723,069 |
RGD:6480464 |
CTD |
| G |
Rabl2 |
RAB, member of RAS oncogene family-like 2 |
|
decreases expression |
EXP |
15 |
89,412,958 |
89,422,354 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
decreases methylation |
ISO |
8 |
13,567,218 |
13,677,587 |
RGD:6480464 |
CTD |
| G |
Rasgef1c |
RasGEF domain family, member 1C |
|
increases methylation |
ISO |
11 |
49,715,337 |
49,793,725 |
RGD:6480464 |
CTD |
| G |
Rasip1 |
Ras interacting protein 1 |
|
decreases methylation |
ISO |
7 |
52,882,907 |
52,894,462 |
RGD:6480464 |
CTD |
| G |
Rbks |
ribokinase |
|
decreases methylation |
ISO |
5 |
31,926,812 |
31,999,983 |
RGD:6480464 |
CTD |
| G |
Rbm3 |
RNA binding motif protein 3 |
|
decreases expression |
ISO |
X |
7,716,101 |
7,722,928 |
RGD:6480464 |
CTD |
| G |
Rbm39 |
RNA binding motif protein 39 |
|
decreases expression |
ISO |
2 |
155,972,975 |
156,005,976 |
RGD:6480464 |
CTD |
| G |
Rbm43 |
RNA binding motif protein 43 |
|
increases expression |
ISO |
2 |
51,779,968 |
51,790,529 |
RGD:6480464 |
CTD |
| G |
Rbm47 |
RNA binding motif protein 47 |
|
increases methylation |
ISO |
5 |
66,407,796 |
66,543,163 |
RGD:6480464 |
CTD |
| G |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
|
decreases expression |
ISO |
10 |
127,566,526 |
127,617,353 |
RGD:6480464 |
CTD |
| G |
Rbms2 |
RNA binding motif, single stranded interacting protein 2 |
|
increases methylation |
ISO |
10 |
127,566,526 |
127,617,353 |
RGD:6480464 |
CTD |
| G |
Rbmx2 |
RNA binding motif protein, X-linked 2 |
|
increases expression |
ISO |
X |
46,048,181 |
46,063,896 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
ISO |
9 |
98,323,380 |
98,346,970 |
RGD:6480464 |
CTD |
| G |
Rbp4 |
retinol binding protein 4, plasma |
|
decreases expression |
ISO |
19 |
38,191,110 |
38,199,811 |
RGD:6480464 |
CTD |
| G |
Rec8 |
REC8 homolog (yeast) |
|
increases expression |
EXP |
14 |
56,237,007 |
56,244,227 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases expression |
EXP |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases response to substance |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
multiple interactions |
ISO |
6 |
118,101,766 |
118,147,762 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
decreases expression |
EXP |
8 |
3,655,789 |
3,658,096 |
RGD:6480464 |
CTD |
| G |
Retn |
resistin |
|
increases methylation |
ISO |
8 |
3,655,789 |
3,658,096 |
RGD:6480464 |
CTD |
| G |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
|
increases expression |
ISO |
6 |
72,548,622 |
72,557,482 |
RGD:6480464 |
CTD |
| G |
Rfc3 |
replication factor C (activator 1) 3 |
|
increases methylation |
ISO |
5 |
152,445,399 |
152,453,783 |
RGD:6480464 |
CTD |
| G |
Rgr |
retinal G protein coupled receptor |
|
decreases methylation |
ISO |
14 |
37,850,676 |
37,862,150 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
affects methylation |
ISO |
1 |
155,587,483 |
155,592,598 |
RGD:6480464 |
CTD |
| G |
Rgs20 |
regulator of G-protein signaling 20 |
|
decreases methylation |
ISO |
1 |
4,899,657 |
5,060,366 |
RGD:6480464 |
CTD |
| G |
Rhag |
Rhesus blood group-associated A glycoprotein |
|
increases expression |
ISO |
17 |
40,948,098 |
40,977,703 |
RGD:6480464 |
CTD |
| G |
Rhbdf1 |
rhomboid family 1 (Drosophila) |
|
increases methylation |
ISO |
11 |
32,109,585 |
32,122,293 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog gene family, member A |
|
increases methylation |
ISO |
9 |
108,208,536 |
108,240,270 |
RGD:6480464 |
CTD |
| G |
Rhoq |
ras homolog gene family, member Q |
|
decreases methylation |
ISO |
17 |
87,362,451 |
87,399,409 |
RGD:6480464 |
CTD |
| G |
Rhot2 |
ras homolog gene family, member T2 |
|
increases methylation |
ISO |
17 |
25,975,783 |
25,981,796 |
RGD:6480464 |
CTD |
| G |
Rilpl2 |
Rab interacting lysosomal protein-like 2 |
|
decreases expression |
ISO |
5 |
124,913,274 |
124,928,244 |
RGD:6480464 |
CTD |
| G |
Riok3 |
RIO kinase 3 |
|
affects expression |
ISO |
18 |
12,287,359 |
12,315,876 |
RGD:6480464 |
CTD |
| G |
Rlim |
ring finger protein, LIM domain interacting |
|
increases expression |
ISO |
X |
101,152,506 |
101,176,623 |
RGD:6480464 |
CTD |
| G |
Rnasek |
ribonuclease, RNase K |
|
increases methylation |
ISO |
11 |
70,051,625 |
70,053,354 |
RGD:6480464 |
CTD |
| G |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
|
decreases expression |
ISO |
1 |
155,596,556 |
155,611,351 |
RGD:6480464 |
CTD |
| G |
Rnd1 |
Rho family GTPase 1 |
|
affects expression |
ISO |
15 |
98,499,636 |
98,507,892 |
RGD:6480464 |
CTD |
| G |
Rnf126 |
ring finger protein 126 |
|
decreases methylation |
ISO |
10 |
79,221,260 |
79,229,686 |
RGD:6480464 |
CTD |
| G |
Rnf128 |
ring finger protein 128 |
|
increases expression |
EXP |
X |
136,145,159 |
136,207,684 |
RGD:6480464 |
CTD |
| G |
Rnf141 |
ring finger protein 141 |
|
decreases methylation |
ISO |
7 |
117,960,049 |
117,987,895 |
RGD:6480464 |
CTD |
| G |
Rnf145 |
ring finger protein 145 |
|
decreases expression |
ISO |
11 |
44,332,466 |
44,379,022 |
RGD:6480464 |
CTD |
| G |
Rnf152 |
ring finger protein 152 |
|
decreases methylation |
ISO |
1 |
107,173,494 |
107,253,287 |
RGD:6480464 |
CTD |
| G |
Rnf222 |
ring finger protein 222 |
|
increases methylation |
ISO |
11 |
68,702,055 |
68,708,517 |
RGD:6480464 |
CTD |
| G |
Rnps1 |
ribonucleic acid binding protein S1 |
|
decreases methylation |
ISO |
17 |
24,551,620 |
24,562,843 |
RGD:6480464 |
CTD |
| G |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
|
decreases methylation |
ISO |
13 |
53,204,686 |
53,381,478 |
RGD:6480464 |
CTD |
| G |
Rora |
RAR-related orphan receptor alpha |
|
affects expression |
EXP |
9 |
68,501,609 |
69,226,838 |
RGD:6480464 |
CTD |
| G |
Rpa3 |
replication protein A3 |
|
increases expression |
ISO |
6 |
8,205,936 |
8,209,141 |
RGD:6480464 |
CTD |
| G |
Rpl10a |
ribosomal protein L10A |
|
decreases methylation |
ISO |
17 |
28,465,416 |
28,467,978 |
RGD:6480464 |
CTD |
| G |
Rpl26 |
ribosomal protein L26 |
|
affects localization |
ISO |
11 |
68,715,068 |
68,718,036 |
RGD:6480464 |
CTD |
| G |
Rpl36 |
ribosomal protein L36 |
|
decreases methylation |
ISO |
17 |
56,752,818 |
56,753,669 |
RGD:6480464 |
CTD |
| G |
Rpl41 |
ribosomal protein L41 |
|
decreases methylation |
ISO |
10 |
127,985,166 |
127,986,224 |
RGD:6480464 |
CTD |
| G |
Rpl7 |
ribosomal protein L7 |
|
decreases expression |
ISO |
1 |
16,091,376 |
16,094,514 |
RGD:6480464 |
CTD |
| G |
Rpl7 |
ribosomal protein L7 |
|
multiple interactions |
EXP |
1 |
16,091,376 |
16,094,514 |
RGD:6480464 |
CTD |
| G |
Rpl7l1 |
ribosomal protein L7-like 1 |
|
decreases expression |
EXP |
17 |
46,910,856 |
46,919,605 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
ISO |
7 |
25,669,733 |
25,674,821 |
RGD:6480464 |
CTD |
| G |
Rps24 |
ribosomal protein S24 |
|
increases expression |
ISO |
14 |
25,309,903 |
25,315,368 |
RGD:6480464 |
CTD |
| G |
Rtf1 |
Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
119,500,804 |
119,561,143 |
RGD:6480464 |
CTD |
| G |
Sash1 |
SAM and SH3 domain containing 1 |
|
increases expression |
EXP |
10 |
8,442,017 |
8,605,868 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
decreases expression |
ISO |
15 |
3,220,767 |
3,230,508 |
RGD:6480464 |
CTD |
| G |
Sepp1 |
selenoprotein P, plasma, 1 |
|
multiple interactions |
ISO |
15 |
3,220,767 |
3,230,508 |
RGD:6480464 |
CTD |
| G |
Serpina6 |
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
|
decreases expression |
ISO |
12 |
104,884,842 |
104,895,281 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) peptidase inhibitor, clade B, member 1a |
|
decreases expression |
ISO |
13 |
32,933,961 |
32,943,054 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) peptidase inhibitor, clade B, member 1a |
|
increases expression |
ISO |
13 |
32,933,961 |
32,943,054 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
|
increases expression |
EXP |
1 |
109,408,000 |
109,422,177 |
RGD:6480464 |
CTD |
| G |
Serpinc1 |
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 |
|
decreases expression |
ISO |
1 |
162,908,737 |
162,933,146 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
|
increases expression |
ISO |
1 |
79,790,896 |
79,855,240 |
RGD:6480464 |
CTD |
| G |
Serpinf1 |
serine (or cysteine) peptidase inhibitor, clade F, member 1 |
|
increases expression |
ISO |
11 |
75,223,531 |
75,236,125 |
RGD:6480464 |
CTD |
| G |
Sfrp1 |
secreted frizzled-related protein 1 |
|
increases expression |
ISO |
8 |
24,521,974 |
24,560,104 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
increases expression |
ISO |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Shb |
src homology 2 domain-containing transforming protein B |
|
decreases expression |
ISO |
4 |
45,436,148 |
45,543,700 |
RGD:6480464 |
CTD |
| G |
Siah2 |
seven in absentia 2 |
|
increases expression |
EXP |
3 |
58,478,871 |
58,496,310 |
RGD:6480464 |
CTD |
| G |
Skp2 |
S-phase kinase-associated protein 2 (p45) |
|
increases expression |
EXP |
15 |
9,041,742 |
9,070,207 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases expression |
ISO |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
|
increases expression |
EXP |
1 |
166,179,186 |
166,195,500 |
RGD:6480464 |
CTD |
| G |
Slc20a2 |
solute carrier family 20, member 2 |
|
affects expression |
EXP |
8 |
23,587,172 |
23,680,088 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/cation transporter), member 12 |
|
increases expression |
ISO |
19 |
6,535,854 |
6,543,070 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases expression |
ISO |
4 |
118,781,350 |
118,809,935 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
multiple interactions |
ISO |
6 |
122,677,827 |
122,692,763 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression |
ISO |
1 |
45,964,915 |
45,982,439 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression |
ISO |
1 |
45,964,915 |
45,982,439 |
RGD:6480464 |
CTD |
| G |
Slc46a1 |
solute carrier family 46, member 1 |
|
increases expression |
ISO |
11 |
78,279,203 |
78,285,447 |
RGD:6480464 |
CTD |
| G |
Slc4a8 |
solute carrier family 4 (anion exchanger), member 8 |
|
increases expression |
ISO |
15 |
100,592,178 |
100,654,402 |
RGD:6480464 |
CTD |
| G |
Slc6a7 |
solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 |
|
increases expression |
ISO |
18 |
61,155,034 |
61,173,853 |
RGD:6480464 |
CTD |
| G |
Slc7a6os |
solute carrier family 7, member 6 opposite strand |
|
decreases expression |
EXP |
8 |
108,724,338 |
108,734,833 |
RGD:6480464 |
CTD |
| G |
Slc7a9 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 |
|
increases expression |
ISO |
7 |
36,234,198 |
36,251,018 |
RGD:6480464 |
CTD |
| G |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
|
decreases expression |
ISO |
4 |
132,925,687 |
132,979,613 |
RGD:6480464 |
CTD |
| G |
Smurf1 |
SMAD specific E3 ubiquitin protein ligase 1 |
|
increases expression |
EXP |
5 |
145,637,364 |
145,726,699 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha |
|
increases expression |
EXP |
6 |
60,681,567 |
60,779,849 |
RGD:6480464 |
CTD |
| G |
Snhg3 |
small nucleolar RNA host gene (non-protein coding) 3 |
|
decreases expression |
EXP |
4 |
131,907,848 |
131,909,601 |
RGD:6480464 |
CTD |
| G |
Snrnp200 |
small nuclear ribonucleoprotein 200 (U5) |
|
increases expression |
EXP |
2 |
127,034,140 |
127,066,187 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
EXP |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases activity |
EXP |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases expression |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sost |
sclerostin |
|
increases expression |
ISO |
11 |
101,823,772 |
101,828,329 |
RGD:6480464 |
CTD |
| G |
Sowahb |
sosondowah ankyrin repeat domain family member B |
|
decreases expression |
ISO |
5 |
93,470,149 |
93,474,048 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
affects response to substance |
ISO |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp1 |
trans-acting transcription factor 1 |
|
multiple interactions |
EXP |
15 |
102,236,747 |
102,266,835 |
RGD:6480464 |
CTD |
| G |
Sp110 |
Sp110 nuclear body protein |
|
multiple interactions |
EXP |
1 |
87,473,474 |
87,500,466 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
decreases expression |
ISO |
11 |
55,208,003 |
55,233,582 |
RGD:6480464 |
CTD |
| G |
Sparcl1 |
SPARC-like 1 |
|
increases methylation |
ISO |
5 |
104,508,127 |
104,543,107 |
RGD:6480464 |
CTD |
| G |
Spata4 |
spermatogenesis associated 4 |
|
decreases methylation |
ISO |
8 |
55,686,134 |
55,695,451 |
RGD:6480464 |
CTD |
| G |
Spats2l |
spermatogenesis associated, serine-rich 2-like |
|
increases methylation |
ISO |
1 |
57,831,705 |
58,005,241 |
RGD:6480464 |
CTD |
| G |
Spdef |
SAM pointed domain containing ets transcription factor |
|
decreases methylation |
ISO |
17 |
27,851,392 |
27,865,896 |
RGD:6480464 |
CTD |
| G |
Specc1l |
sperm antigen with calponin homology and coiled-coil domains 1-like |
|
decreases methylation |
ISO |
10 |
74,674,818 |
74,775,145 |
RGD:6480464 |
CTD |
| G |
Spem1 |
sperm maturation 1 |
|
increases expression |
ISO |
11 |
69,634,373 |
69,635,667 |
RGD:6480464 |
CTD |
| G |
Spink3 |
serine peptidase inhibitor, Kazal type 3 |
|
multiple interactions |
ISO |
18 |
43,887,723 |
43,896,891 |
RGD:6480464 |
CTD |
| G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
|
decreases methylation |
ISO |
4 |
40,867,089 |
40,878,428 |
RGD:6480464 |
CTD |
| G |
Spns2 |
spinster homolog 2 |
|
decreases expression |
ISO |
11 |
72,265,140 |
72,303,406 |
RGD:6480464 |
CTD |
| G |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
|
decreases methylation |
ISO |
8 |
65,430,243 |
65,835,895 |
RGD:6480464 |
CTD |
| G |
Spon2 |
spondin 2, extracellular matrix protein |
|
decreases expression |
ISO |
5 |
33,556,167 |
33,560,887 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
decreases expression |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
multiple interactions |
EXP |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Spp2 |
secreted phosphoprotein 2 |
|
increases expression |
ISO |
1 |
90,303,594 |
90,323,013 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
multiple interactions |
EXP |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Srebf2 |
sterol regulatory element binding factor 2 |
|
increases expression |
ISO |
15 |
81,977,699 |
82,035,390 |
RGD:6480464 |
CTD |
| G |
Srpk1 |
serine/arginine-rich protein specific kinase 1 |
|
decreases methylation |
ISO |
17 |
28,726,537 |
28,759,399 |
RGD:6480464 |
CTD |
| G |
Srpr |
signal recognition particle receptor ('docking protein') |
|
increases expression |
ISO |
9 |
35,018,788 |
35,024,588 |
RGD:6480464 |
CTD |
| G |
Srsf2 |
serine/arginine-rich splicing factor 2 |
|
increases expression |
ISO |
11 |
116,711,211 |
116,714,408 |
RGD:6480464 |
CTD |
| G |
Srsf6 |
serine/arginine-rich splicing factor 6 |
|
decreases expression |
ISO |
2 |
162,757,244 |
162,762,857 |
RGD:6480464 |
CTD |
| G |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
151,931,466 |
151,937,089 |
RGD:6480464 |
CTD |
| G |
Ssna1 |
Sjogren's syndrome nuclear autoantigen 1 |
|
decreases methylation |
ISO |
2 |
25,126,559 |
25,127,938 |
RGD:6480464 |
CTD |
| G |
Sspn |
sarcospan |
|
multiple interactions |
ISO |
6 |
145,882,667 |
145,913,745 |
RGD:6480464 |
CTD |
| G |
Ssr1 |
signal sequence receptor, alpha |
|
decreases methylation |
ISO |
13 |
38,063,270 |
38,086,059 |
RGD:6480464 |
CTD |
| G |
Ssrp1 |
structure specific recognition protein 1 |
|
decreases expression |
ISO |
2 |
84,877,358 |
84,887,268 |
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
decreases expression |
ISO |
15 |
66,934,437 |
67,008,444 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
8 |
26,918,985 |
26,926,454 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
8 |
26,918,985 |
26,926,454 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
multiple interactions |
ISO |
11 |
100,748,124 |
100,800,825 |
RGD:6480464 |
CTD |
| G |
Stau2 |
staufen (RNA binding protein) homolog 2 (Drosophila) |
|
increases expression |
EXP |
1 |
16,218,891 |
16,509,383 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
ISO |
4 |
134,024,235 |
134,029,758 |
RGD:6480464 |
CTD |
| G |
Stmn4 |
stathmin-like 4 |
|
decreases expression |
ISO |
14 |
66,963,212 |
66,980,517 |
RGD:6480464 |
CTD |
| G |
Stom |
stomatin |
|
multiple interactions |
ISO |
2 |
35,169,510 |
35,192,529 |
RGD:6480464 |
CTD |
| G |
Synrg |
synergin, gamma |
|
decreases expression |
ISO |
11 |
83,777,930 |
83,855,591 |
RGD:6480464 |
CTD |
| G |
Tac4 |
tachykinin 4 |
|
increases expression |
ISO |
11 |
95,122,843 |
95,130,576 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
increases expression |
ISO |
9 |
15,110,658 |
15,121,441 |
RGD:6480464 |
CTD |
| G |
Taf1d |
TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D |
|
decreases expression |
EXP |
9 |
15,110,658 |
15,121,441 |
RGD:6480464 |
CTD |
| G |
Tars2 |
threonyl-tRNA synthetase 2, mitochondrial (putative) |
|
decreases expression |
EXP |
3 |
95,543,897 |
95,558,900 |
RGD:6480464 |
CTD |
| G |
Tbce |
tubulin-specific chaperone E |
|
affects expression |
EXP |
13 |
14,090,218 |
14,131,867 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
multiple interactions |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases expression |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
1 |
188,447,065 |
188,529,871 |
RGD:6480464 |
CTD |
| G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
|
decreases expression |
EXP |
2 |
84,667,178 |
84,670,370 |
RGD:6480464 |
CTD |
| G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
|
decreases expression |
ISO |
4 |
129,842,844 |
129,852,366 |
RGD:6480464 |
CTD |
| G |
Tlr2 |
toll-like receptor 2 |
|
decreases expression |
EXP |
3 |
83,640,194 |
83,645,530 |
RGD:6480464 |
CTD |
| G |
Tm4sf1 |
transmembrane 4 superfamily member 1 |
|
multiple interactions |
ISO |
3 |
57,090,986 |
57,105,841 |
RGD:6480464 |
CTD |
| G |
Tmem48 |
transmembrane protein 48 |
|
decreases expression |
EXP |
4 |
107,040,389 |
107,086,943 |
RGD:6480464 |
CTD |
| G |
Tmem57 |
transmembrane protein 57 |
|
increases methylation |
ISO |
4 |
134,358,674 |
134,409,260 |
RGD:6480464 |
CTD |
| G |
Tmem57 |
transmembrane protein 57 |
|
affects methylation |
ISO |
4 |
134,358,674 |
134,409,260 |
RGD:6480464 |
CTD |
| G |
Tmem66 |
transmembrane protein 66 |
|
decreases methylation |
ISO |
8 |
35,217,617 |
35,233,901 |
RGD:6480464 |
CTD |
| G |
Tmem67 |
transmembrane protein 67 |
|
increases methylation |
ISO |
4 |
11,966,502 |
12,015,104 |
RGD:6480464 |
CTD |
| G |
Tmem69 |
transmembrane protein 69 |
|
decreases expression |
EXP |
4 |
116,224,133 |
116,228,548 |
RGD:6480464 |
CTD |
| G |
Tmf1 |
TATA element modulatory factor 1 |
|
decreases expression |
ISO |
6 |
97,101,944 |
97,129,118 |
RGD:6480464 |
CTD |
| G |
Tmlhe |
trimethyllysine hydroxylase, epsilon |
|
decreases methylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tmprss11c |
transmembrane protease, serine 11c |
|
decreases methylation |
ISO |
5 |
86,660,506 |
86,718,333 |
RGD:6480464 |
CTD |
| G |
Tmprss11d |
transmembrane protease, serine 11d |
|
increases methylation |
ISO |
5 |
86,731,879 |
86,802,412 |
RGD:6480464 |
CTD |
| G |
Tmprss3 |
transmembrane protease, serine 3 |
|
decreases methylation |
ISO |
17 |
31,316,210 |
31,335,919 |
RGD:6480464 |
CTD |
| G |
Tmprss9 |
transmembrane protease, serine 9 |
|
decreases expression |
ISO |
10 |
80,342,561 |
80,362,239 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
increases expression |
ISO |
6 |
72,907,341 |
72,908,742 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
affects expression |
ISO |
6 |
72,907,341 |
72,908,742 |
RGD:6480464 |
CTD |
| G |
Tmsb4x |
thymosin, beta 4, X chromosome |
|
decreases expression |
ISO |
X |
163,645,026 |
163,647,150 |
RGD:6480464 |
CTD |
| G |
Tmx1 |
thioredoxin-related transmembrane protein 1 |
|
increases expression |
ISO |
12 |
71,554,141 |
71,568,611 |
RGD:6480464 |
CTD |
| G |
Tmx4 |
thioredoxin-related transmembrane protein 4 |
|
increases expression |
EXP |
2 |
134,420,237 |
134,469,857 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases secretion |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases methylation |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
|
decreases expression |
ISO |
12 |
112,680,872 |
112,693,229 |
RGD:6480464 |
CTD |
| G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
|
increases expression |
ISO |
10 |
18,720,716 |
18,735,216 |
RGD:6480464 |
CTD |
| G |
Tnfaip8l3 |
tumor necrosis factor, alpha-induced protein 8-like 3 |
|
increases expression |
ISO |
9 |
53,873,413 |
53,916,218 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a |
|
multiple interactions |
EXP |
1 |
107,677,300 |
107,744,558 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
decreases methylation |
ISO |
17 |
23,812,412 |
23,814,416 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
affects expression |
ISO |
17 |
23,812,412 |
23,814,416 |
RGD:6480464 |
CTD |
| G |
Tnfrsf12a |
tumor necrosis factor receptor superfamily, member 12a |
|
increases expression |
ISO |
17 |
23,812,412 |
23,814,416 |
RGD:6480464 |
CTD |
| G |
Tnfrsf17 |
tumor necrosis factor receptor superfamily, member 17 |
|
increases methylation |
ISO |
16 |
11,313,902 |
11,320,161 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
4 |
144,802,271 |
144,836,773 |
RGD:6480464 |
CTD |
| G |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
|
affects expression |
ISO |
17 |
43,153,504 |
43,226,137 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
ISO |
3 |
27,215,999 |
27,238,587 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
|
decreases methylation |
ISO |
8 |
35,892,233 |
36,028,744 |
RGD:6480464 |
CTD |
| G |
Tnp2 |
transition protein 2 |
|
increases methylation |
ISO |
16 |
10,788,028 |
10,788,748 |
RGD:6480464 |
CTD |
| G |
Tns4 |
tensin 4 |
|
increases expression |
ISO |
11 |
98,926,992 |
98,950,620 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
decreases expression |
ISO |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Traf2 |
TNF receptor-associated factor 2 |
|
decreases expression |
ISO |
2 |
25,373,502 |
25,402,414 |
RGD:6480464 |
CTD |
| G |
Trim24 |
tripartite motif-containing 24 |
|
affects expression |
ISO |
6 |
37,820,811 |
37,916,292 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif-containing 6 |
|
affects expression |
ISO |
7 |
111,367,309 |
111,383,666 |
RGD:6480464 |
CTD |
| G |
Trim71 |
tripartite motif-containing 71 |
|
decreases expression |
ISO |
9 |
114,420,386 |
114,473,487 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases phosphorylation |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases activity |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
affects response to substance |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases expression |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
decreases activity |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
increases phosphorylation |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
affects response to substance |
EXP |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53rk |
transformation related protein 53 regulating kinase |
|
decreases expression |
EXP |
2 |
166,619,267 |
166,624,992 |
RGD:6480464 |
CTD |
| G |
Trpc2 |
transient receptor potential cation channel, subfamily C, member 2 |
|
affects expression |
EXP |
7 |
109,214,227 |
109,244,930 |
RGD:6480464 |
CTD |
| G |
Tsacc |
TSSK6 activating co-chaperone |
|
increases methylation |
ISO |
3 |
88,086,682 |
88,100,760 |
RGD:6480464 |
CTD |
| G |
Tsen2 |
tRNA splicing endonuclease 2 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
6 |
115,494,722 |
115,528,354 |
RGD:6480464 |
CTD |
| G |
Tsfm |
Ts translation elongation factor, mitochondrial |
|
decreases expression |
EXP |
10 |
126,459,388 |
126,467,870 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta subunit |
|
decreases expression |
ISO |
3 |
102,581,321 |
102,586,637 |
RGD:6480464 |
CTD |
| G |
Tshb |
thyroid stimulating hormone, beta subunit |
|
multiple interactions |
ISO |
3 |
102,581,321 |
102,586,637 |
RGD:6480464 |
CTD |
| G |
Ttc4 |
tetratricopeptide repeat domain 4 |
|
decreases expression |
ISO |
4 |
106,334,413 |
106,351,549 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
4 |
57,956,245 |
57,969,283 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
ISO |
10 |
82,296,696 |
82,360,469 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
10 |
82,296,696 |
82,360,469 |
RGD:6480464 |
CTD |
| G |
Tysnd1 |
trypsin domain containing 1 |
|
decreases expression |
EXP |
10 |
61,158,262 |
61,165,521 |
RGD:6480464 |
CTD |
| G |
Tyw3 |
tRNA-yW synthesizing protein 3 homolog (S. cerevisiae) |
|
decreases expression |
EXP |
3 |
154,239,484 |
154,260,062 |
RGD:6480464 |
CTD |
| G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
|
decreases expression |
EXP |
2 |
164,595,429 |
164,598,402 |
RGD:6480464 |
CTD |
| G |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
|
increases expression |
ISO |
3 |
135,101,723 |
135,130,142 |
RGD:6480464 |
CTD |
| G |
Ube2f |
ubiquitin-conjugating enzyme E2F (putative) |
|
increases expression |
EXP |
1 |
93,146,896 |
93,182,602 |
RGD:6480464 |
CTD |
| G |
Ube2j1 |
ubiquitin-conjugating enzyme E2J 1 |
|
increases expression |
EXP |
4 |
33,118,400 |
33,139,339 |
RGD:6480464 |
CTD |
| G |
Ube2k |
ubiquitin-conjugating enzyme E2K |
|
increases expression |
EXP |
5 |
65,928,500 |
65,990,228 |
RGD:6480464 |
CTD |
| G |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
|
decreases expression |
EXP |
2 |
84,638,985 |
84,650,160 |
RGD:6480464 |
CTD |
| G |
Ube2q1 |
ubiquitin-conjugating enzyme E2Q (putative) 1 |
|
increases expression |
EXP |
3 |
89,577,531 |
89,587,919 |
RGD:6480464 |
CTD |
| G |
Ube2t |
ubiquitin-conjugating enzyme E2T (putative) |
|
decreases expression |
EXP |
1 |
136,859,154 |
136,870,714 |
RGD:6480464 |
CTD |
| G |
Ube2w |
ubiquitin-conjugating enzyme E2W (putative) |
|
increases expression |
EXP |
1 |
16,559,487 |
16,609,367 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxy-terminal hydrolase L1 |
|
increases expression |
EXP |
5 |
67,067,360 |
67,078,473 |
RGD:6480464 |
CTD |
| G |
Upf3b |
UPF3 regulator of nonsense transcripts homolog B (yeast) |
|
increases expression |
EXP |
X |
34,631,829 |
34,650,317 |
RGD:6480464 |
CTD |
| G |
Usp2 |
ubiquitin specific peptidase 2 |
|
decreases expression |
EXP |
9 |
43,875,104 |
43,903,710 |
RGD:6480464 |
CTD |
| G |
Usp26 |
ubiquitin specific peptidase 26 |
|
increases expression |
EXP |
X |
49,107,136 |
49,154,410 |
RGD:6480464 |
CTD |
| G |
Usp29 |
ubiquitin specific peptidase 29 |
|
increases expression |
EXP |
7 |
6,683,452 |
6,919,931 |
RGD:6480464 |
CTD |
| G |
Usp38 |
ubiquitin specific peptidase 38 |
|
increases expression |
EXP |
8 |
83,504,632 |
83,538,805 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
ISO |
11 |
52,174,617 |
52,202,898 |
RGD:6480464 |
CTD |
| G |
Vezf1 |
vascular endothelial zinc finger 1 |
|
decreases expression |
ISO |
11 |
87,881,843 |
87,898,231 |
RGD:6480464 |
CTD |
| G |
Vim |
vimentin |
|
multiple interactions |
ISO |
2 |
13,495,938 |
13,504,453 |
RGD:6480464 |
CTD |
| G |
Vmn1r224 |
vomeronasal 1 receptor 224 |
|
increases expression |
ISO |
17 |
20,556,127 |
20,557,023 |
RGD:6480464 |
CTD |
| G |
Wisp1 |
WNT1 inducible signaling pathway protein 1 |
|
increases expression |
ISO |
15 |
66,722,955 |
66,754,761 |
RGD:6480464 |
CTD |
| G |
Wisp2 |
WNT1 inducible signaling pathway protein 2 |
|
decreases expression |
EXP |
2 |
163,646,570 |
163,658,882 |
RGD:6480464 |
CTD |
| G |
Wnt1 |
wingless-related MMTV integration site 1 |
|
multiple interactions |
ISO |
15 |
98,620,288 |
98,624,261 |
RGD:6480464 |
CTD |
| G |
Wnt2 |
wingless-related MMTV integration site 2 |
|
multiple interactions |
ISO |
6 |
17,938,940 |
17,980,445 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
decreases activity |
ISO |
4 |
46,188,094 |
46,209,183 |
RGD:6480464 |
CTD |
| G |
Xpa |
xeroderma pigmentosum, complementation group A |
|
multiple interactions |
ISO |
4 |
46,188,094 |
46,209,183 |
RGD:6480464 |
CTD |
| G |
Zbtb25 |
zinc finger and BTB domain containing 25 |
|
increases expression |
EXP |
12 |
77,449,887 |
77,470,547 |
RGD:6480464 |
CTD |
| G |
Zdhhc6 |
zinc finger, DHHC domain containing 6 |
|
decreases expression |
EXP |
19 |
55,372,786 |
55,390,522 |
RGD:6480464 |
CTD |
| G |
Zfp185 |
zinc finger protein 185 |
|
increases expression |
EXP |
X |
70,232,678 |
70,276,882 |
RGD:6480464 |
CTD |
| G |
Zfp418 |
zinc finger protein 418 |
|
increases expression |
ISO |
7 |
7,124,064 |
7,136,271 |
RGD:6480464 |
CTD |
| G |
Zranb1 |
zinc finger, RAN-binding domain containing 1 |
|
increases expression |
ISO |
7 |
140,141,305 |
140,175,634 |
RGD:6480464 |
CTD |
| G |
Zscan22 |
zinc finger and SCAN domain containing 22 |
|
decreases expression |
EXP |
7 |
13,483,164 |
13,493,588 |
RGD:6480464 |
CTD |
Term paths to the root
|